Novozymes A/S B buy RudolfL
Start price
26.01.20
/
50%
€46.87
Target price
13.08.20
€53.00
Performance (%)
5.33%
End price
13.08.20
€49.37
Summary
This prediction ended on 13.08.20 with a price of €49.37. With a performance of 5.33%, the BUY prediction by RudolfL for Novozymes A/S B closed with a slight gain. Dividends of €0.70 are taken into consideration when calculating the performance. RudolfL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novozymes A/S B | 1.205% | 1.205% | 0.351% | 30.783% |
| iShares Core DAX® | 2.573% | 3.502% | 8.408% | 62.272% |
| iShares Nasdaq 100 | 4.858% | 0.654% | 28.383% | 85.454% |
| iShares Nikkei 225® | 5.590% | -0.246% | 52.915% | 76.580% |
| iShares S&P 500 | 3.250% | 2.083% | 24.370% | 68.715% |
According to RudolfL what are the pros and cons of Novozymes A/S B for the foreseeable future?
Pros
Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
ROE higher than 15% per year
Cons
Revenue decline/stagnation expected
Comments by RudolfL for this prediction
In the thread Novozymes A/s Nam. B diskutieren
In the thread Trading Novozymes A/s Nam. B
Stopped prediction by RudolfL for Novozymes A/S B
Novozymes A/S B
Start price
Target price
Perf. (%)
€55.52
11.09.20
11.09.20
€63.00
04.11.21
04.11.21
18.70%
05.11.21
05.11.21
Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
Revenue decline/stagnation expected
